FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

424646001: Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3678502014 Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3678504010 Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet est un(e) (attribut) Efavirenz and emtricitabine and tenofovir only product in oral dose form true Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Plays role Antiretroviral therapeutic role true Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet est un(e) (attribut) médicament contenant éfavirenz et emtricitabine et ténofovir false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a pour principe actif (attribut) Emtricitabine (substance) false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a pour principe actif (attribut) Tenofovir disoproxil fumarate (substance) false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a pour principe actif (attribut) Efavirenz (substance) false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a une forme pharmaceutique (attribut) comprimé false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a une forme pharmaceutique (attribut) Oral tablet true Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet est un(e) (attribut) Product manufactured as oral dose form (product) false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet est un(e) (attribut) Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) false Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a pour principe actif (attribut) Tenofovir disoproxil fumarate (substance) false Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) Tenofovir disoproxil fumarate (substance) true Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator value (attribute) 300 (qualifier value) false Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a pour principe actif (attribut) Efavirenz (substance) false Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) Efavirenz (substance) true Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator value (attribute) 600 (qualifier value) false Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet a pour principe actif (attribut) Emtricitabine (substance) false Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) Emtricitabine (substance) true Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator value (attribute) 200 (qualifier value) false Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient Tenofovir disoproxil fumarate (substance) true Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient Efavirenz (substance) true Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient Emtricitabine (substance) true Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Count of base of active ingredient trois false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start